Harrow, Inc.
HROW
#5854
Rank
A$1.80 B
Marketcap
A$48.07
Share price
-5.74%
Change (1 day)
-18.94%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): A$19.37 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are A$0.26 Billion. In 2025 the company made an earning of A$31.8 Million, an increase over its 2024 earnings that were of A$7.62 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$19.37 M-39.09%
2025 A$31.8 M317.34%
2024 A$7.62 M-329.09%
2023 -A$3.33 Million-224.34%
2022 A$2.67 M3.01%
2021 A$2.59 M149.06%
2020 A$1.04 M434.29%
2019 A$0.19 M-102.68%
2018 -A$7.28 Million-57.11%
2017 -A$16.96 Million-21.93%
2016 -A$21.73 Million5.11%
2015 -A$20.67 Million46.16%
2014 -A$14.14 Million32.68%
2013 -A$10.66 Million42.63%
2012 -A$7.48 Million
2010 -A$3.46 Million-45.76%
2009 -A$6.37 Million21.83%
2008 -A$5.23 Million-491.97%
2007 A$1.33 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.32 Billion-2,013.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.32 Million-251.76%๐Ÿ‡บ๐Ÿ‡ธ USA